{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:35:24Z","timestamp":1792175724497,"version":"4.4.0"},"reference-count":188,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Viral diseases are one of the major causes of mortality worldwide. The emergence of\npandemics because of the COVID virus creates a dire need for an efficient mechanism to combat\nthe disease. Viruses differ from other pathogenic infections; they render the host immune system\nvulnerable. One of the major challenges for developing antivirals is the resistance developed by the\noveruse of drugs, which is inevitable as most viral diseases require a large number of doses. Viral\ninfection detection, prevention, and treatment have significantly benefitted from developing several\ninnovative technologies in recent years. Nanotechnology has emerged as one of the most promising\ntechnologies because of its capacity to deal with viral infections efficiently and eradicate the\nlagging of conventional antiviral drugs. This review briefly presents an overview of the application\nof nanotechnology for viral therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211738511666221201154154","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T04:11:26Z","timestamp":1670213486000},"page":"105-126","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nanoformulation-based Drug Delivery System for Viral Diseases"],"prefix":"10.2174","volume":"11","author":[{"given":"Manisha","family":"Bharti","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Aftab","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudhanti Siva Nago","family":"Koteswara Rao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh","family":"Varshney","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"84","volume":"3","author":"Maravajhala V.","year":"2012","unstructured":"Maravajhala V.; Papishetty S.; Bandlapalli S.; Nanotechnology in development of drug delivery system. Int J Pharm 2012,3(1),84","journal-title":"Int J Pharm"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12030-009-9028-2","volume":"5","author":"Ravichandran R.","year":"2009","unstructured":"Ravichandran R.; Nanotechnology-based drug delivery systems. NanoBiotechnology 2009,5(1-4),17-33","journal-title":"NanoBiotechnology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1119\/1.2213634","volume":"74","author":"Junk A.","year":"2006","unstructured":"Junk A.; Riess F.; From an idea to a vision: There\u2019s plenty of room at the bottom. Am J Phys 2006,74(9),825-830","journal-title":"Am J Phys"},{"key":"ref=4","first-page":"165","author":"Ramsden J.","year":"2013","unstructured":"Ramsden J.;  Applied Nanotechnology: The conversion of research results to products 2013,165-178","journal-title":"Applied Nanotechnology: The conversion of research results to products"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nnano.2006.156","volume":"1","author":"Helmus MN","year":"2006","unstructured":"Helmus MN; How to commercialize nanotechnology. Nat nanotech 2006,1(3),157-8","journal-title":"Nat nanotech"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-5432-7","author":"Roco M.C.","year":"2007","unstructured":"Roco M.C.; Bainbridge W.S.;  Nanotechnology: societal implications: maximizing benefits for humanity 2007","journal-title":"Nanotechnology: societal implications: maximizing benefits for humanity"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.matpr.2020.05.380","volume":"37","author":"Damodharan J.","year":"2021","unstructured":"Damodharan J.; Nanomaterials in medicine-An overview. Mater Today Proc 2021,37,383-385","journal-title":"Mater Today Proc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10856-010-4178-2","volume":"22","author":"Taheri Qazvini N.","year":"2011","unstructured":"Taheri Qazvini N.; Zinatloo S.; Synthesis and characterization of gelatin nanoparticles using CDI\/NHS as a non-toxic cross-linking system. J Mater Sci Mater Med 2011,22(1),63-69","journal-title":"J Mater Sci Mater Med"},{"key":"ref=9","first-page":"267","volume":"4","author":"Zinatloo A.S.","year":"2014","unstructured":"Zinatloo A.S.; Taheri Q.N.; Inverse miniemulsion method for synthesis of gelatin nanoparticles in presence of CDI\/NHS as a non-toxic cross-linking system. J Mater Sci Mater Med 2014,4(3),267-275","journal-title":"J Mater Sci Mater Med"},{"key":"ref=10","first-page":"784","volume":"9","author":"Ajabshir Z.","year":"2019","unstructured":"Ajabshir Z.; Zinatloo-Ajabshir S.; Preparation and characterization of curcumin niosomal nanoparticles via a simple and eco-friendly route. J Nanostruct 2019,9(4),784-790","journal-title":"J Nanostruct"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"105376","DOI":"10.1016\/j.ultsonch.2020.105376","volume":"71","author":"Zinatloo-Ajabshir S.","year":"2021","unstructured":"Zinatloo-Ajabshir S.; Ghasemian N.; Mousavi-Kamazani M.; Salavati-Niasari M.; Effect of zirconia on improving NOx reduction efficiency of Nd2Zr2O7 nanostructure fabricated by a new, facile and green sonochemical approach. Ultrason Sonochem 2021,71(71),105376","journal-title":"Ultrason Sonochem"},{"key":"ref=12","doi-asserted-by":"publisher","author":"Canle M.","unstructured":"Canle M.; Fern\u00e1ndez M.I.; Santaballa J.A.;  Applications of Nanomaterials\nin Environmental Remediation. In: Nanomaterials for Environmental\nApplications. London; CRC Press; pp.1-22.","DOI":"10.1201\/9781003129042-1"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"119841","DOI":"10.1016\/j.seppur.2021.119841","volume":"280","author":"Zinatloo-Ajabshir S.","year":"2022","unstructured":"Zinatloo-Ajabshir S.; Heidari-Asil S.A.; Salavati-Niasari M.; Rapid and green combustion synthesis of nanocomposites based on Zn-Co-O nanostructures as photocatalysts for enhanced degradation of acid brown 14 contaminant under sunlight. Separ Purif Tech 2022,280(280),119841","journal-title":"Separ Purif Tech"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2147\/IJN.S296383","volume":"16","author":"Yang D.","year":"2021","unstructured":"Yang D.; Application of nanotechnology in the COVID-19 pandemic. Int J Nanomedicine 2021,16,623-649","journal-title":"Int J Nanomedicine"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"Dong E.","year":"2020","unstructured":"Dong E.; Du H.; Gardner L.; An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020,20(5),533-534","journal-title":"Lancet Infect Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s13346-020-00818-0","volume":"11","author":"Chakravarty M.","year":"2021","unstructured":"Chakravarty M.; Vora A.; Nanotechnology-based antiviral therapeutics. Drug Deliv Transl Res 2021,11(3),748-787","journal-title":"Drug Deliv Transl Res"},{"key":"ref=17","first-page":"1141","volume":"1","author":"Ranjha M.M.","year":"2021","unstructured":"Ranjha M.M.; Shafique B.; Rehman A.; Biocompatible nanomaterials in food science, technology and nutrient drug delivery: Recent developments and applications. Front Nutr 2021,1,1141","journal-title":"Front Nutr"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2017.1360863","volume":"15","author":"Lembo D.","year":"2018","unstructured":"Lembo D.; Donalisio M.; Civra A.; Argenziano M.; Cavalli R.; Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections. Expert Opin Drug Deliv 2018,15(1),93-114","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4155\/tde-2017-0013","volume":"8","author":"Gagliardi M.","year":"2017","unstructured":"Gagliardi M.; Biomimetic and bioinspired nanoparticles for targeted drug delivery. Ther Deliv 2017,8(5),289-299","journal-title":"Ther Deliv"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-198-1_1","author":"McNeil S.E.","year":"2011","unstructured":"McNeil S.E.; Unique benefits of nanotechnology to drug delivery and diagnostics. In: Characterization of nanoparticles intended for drug delivery 2011,3-8","journal-title":"Characterization of nanoparticles intended for drug delivery"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0959-440X(00)00073-7","volume":"10","author":"Johnson J.","year":"2000","unstructured":"Johnson J.; Chiu W.; Structures of virus and virus-like particles. Curr Opin Struct Biol 2000,10(2),229-235","journal-title":"Curr Opin Struct Biol"},{"key":"ref=22","first-page":"232","author":"Payne S.","year":"2017","unstructured":"Payne S.;  Viruses: From understanding to investigation 2017,232-245","journal-title":"Viruses: From understanding to investigation"},{"key":"ref=23","first-page":"33","author":"Manjarrez-Zavala M.E.","year":"2013","unstructured":"Manjarrez-Zavala M.E.; Rosete-Olvera D.P.; Guti\u00e9rrez-Gonz\u00e1lez L.H.; Ocadiz-Delgado R.; Cabello-Guti\u00e9rrez C.; Pathogenesis of viral respiratory infection. In: Respiratory Disease and Infection: A New Insight 2013,33-77","journal-title":"In: Respiratory Disease and Infection: A New Insight"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1039\/c3cs60198f","volume":"42","author":"Mendes P.M.","year":"2013","unstructured":"Mendes P.M.; Cellular nanotechnology: making biological interfaces smarter. Chem Soc Rev 2013,42(24),9207-9218","journal-title":"Chem Soc Rev"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"132002","DOI":"10.1088\/1361-6528\/ab5bc8","volume":"31","author":"Villanueva-Flores F.","year":"2020","unstructured":"Villanueva-Flores F.; Castro-Lugo A.; Ram\u00edrez O.T.; Palomares L.A.; Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices. Nanotech 2020,31(13),132002","journal-title":"Nanotech"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","volume":"26","author":"Rizvi S.A.A.","year":"2018","unstructured":"Rizvi S.A.A.; Saleh A.M.; Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J 2018,26(1),64-70","journal-title":"Saudi Pharm J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"101031","DOI":"10.1016\/j.nantod.2020.101031","volume":"36","author":"Zhou J.","year":"2021","unstructured":"Zhou J.; Krishnan N.; Jiang Y.; Fang R.H.; Zhang L.; Nanotechnology for virus treatment. Nano Today 2021,36(36),101031","journal-title":"Nano Today"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2147\/TCRM.S44205","volume":"9","author":"Oshikoya K.A.","year":"2013","unstructured":"Oshikoya K.A.; Ogunleye, Lawal, Senbanjo S, Oreagba. Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases. Ther Clin Risk Manag 2013,9,215-221","journal-title":"Ther Clin Risk Manag"},{"key":"ref=29","first-page":"809","volume":"24","author":"Strasfeld L.","year":"2010","unstructured":"Strasfeld L.; Chou S.; Antiviral drug resistance: mechanisms and clinical implications. IDC 2010,24(3),809-833","journal-title":"IDC"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.sbi.2013.03.007","volume":"23","author":"Merk A.","year":"2013","unstructured":"Merk A.; Subramaniam S.; HIV-1 envelope glycoprotein structure. Curr Opin Struct Biol 2013,23(2),268-276","journal-title":"Curr Opin Struct Biol"},{"key":"ref=31","first-page":"978","author":"Nishanth A.N.","year":"2020","unstructured":"Nishanth A.N.; Nivedh K.; Syed N.H.; Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG-NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity. Int J Biol Macromol 2020(144),978-994","journal-title":"Int J Biol Macromol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1172\/JCI200113799","volume":"108","author":"Shukla D.","year":"2001","unstructured":"Shukla D.; Spear P.G.; Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J Clin Invest 2001,108(4),503-510","journal-title":"J Clin Invest"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"Akbarzadeh A.","year":"2013","unstructured":"Akbarzadeh A.; Rezaei-Sadabady R.; Davaran S.; Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013,8(1),102","journal-title":"Nanoscale Res Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/A:1020178304031","volume":"22","author":"Ulrich A.S.","year":"2002","unstructured":"Ulrich A.S.; Biophysical aspects of using liposomes as delivery vehicles. Biosci Rep 2002,22(2),129-150","journal-title":"Biosci Rep"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.36076\/ppj.2013\/16\/E199","volume":"16","author":"Hua S.","year":"2013","unstructured":"Hua S.; Cabot P.J.; Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain conditions. Pain Physician 2013,16(3),199-216","journal-title":"Pain Physician"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/17435889.1.3.297","volume":"1","author":"Immordino M.L.","year":"2006","unstructured":"Immordino M.L.; Dosio F.; Cattel L.; Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006,1(3),297-315","journal-title":"Int J Nanomedicine"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/B978-0-323-51254-1.00012-9","author":"Sudha P.N.","year":"2018","unstructured":"Sudha P.N.; Sangeetha K.; Vijayalakshmi K.; Barhoum A.;  Nanomaterials history, classification, unique properties, production and market Emerging applications of nanoparticles and architecture nanostructures 2018,341-384","journal-title":"Nanomaterials history, classification, unique properties, production and market Emerging applications of nanoparticles and architecture nanostructures"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408436.2012.732545","volume":"38","author":"Amarnath C.A.","year":"2013","unstructured":"Amarnath C.A.; Nanda S.S.; Papaefthymiou G.C.; Yi D.K.; Paik U.; Nanohybridization of low-dimensional nanomaterials: synthesis, classification, and application. Crit Rev Solid State Mater Sci 2013,38(1),1-56","journal-title":"Crit Rev Solid State Mater Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/10717544.2013.839368","volume":"21","author":"Ramyadevi D.","year":"2014","unstructured":"Ramyadevi D.; Sandhya P.; Dual sustained release delivery system for multiple route therapy of an antiviral drug. Drug Deliv 2014,21(4),276-292","journal-title":"Drug Deliv"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2015.01.008","volume":"116","author":"Hendricks G.L.","year":"2015","unstructured":"Hendricks G.L.; Velazquez L.; Pham S.; Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses. Antiviral Res 2015,116(116),34-44","journal-title":"Antiviral Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1021\/acsnano.0c01665","volume":"14","author":"Rao L.","year":"2020","unstructured":"Rao L.; Tian R.; Chen X.; Cell-membrane-mimicking nano decoys against infectious diseases. ACS Nano 2020,14(3),2569-2574","journal-title":"ACS Nano"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/smll.201500854","volume":"12","author":"Jackman J.A.","year":"2016","unstructured":"Jackman J.A.; Lee J.; Cho N.J.; Nanomedicine for infectious disease applications: innovation towards broad-spectrum treatment of viral infections. Small 2016,12(9),1133-1139","journal-title":"Small"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"Patra J.K.","year":"2018","unstructured":"Patra J.K.; Das G.; Fraceto L.F.; Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 2018,16(1),71","journal-title":"J Nanobiotechnology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"Mitchell M.J.","year":"2021","unstructured":"Mitchell M.J.; Billingsley M.M.; Haley R.M.; Wechsler M.E.; Peppas N.A.; Langer R.; Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021,20(2),101-124","journal-title":"Nat Rev Drug Discov"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1905013","DOI":"10.1002\/smll.201905013","volume":"16","author":"Pant K.","year":"2020","unstructured":"Pant K.; Neuber C.; Zarschler K.; Active targeting of dendritic polyglycerols for diagnostic cancer imaging. Small 2020,16(7),1905013","journal-title":"Small"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","volume":"25","author":"Yetisgin A.A.","year":"2020","unstructured":"Yetisgin A.A.; Cetinel S.; Zuvin M.; Kosar A.; Kutlu O.; Therapeutic nanoparticles and their targeted delivery applications. Molecules 2020,25(9),2193","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4161\/viru.2.5.17035","volume":"2","author":"Blecher K.","year":"2011","unstructured":"Blecher K.; Nasir A.; Friedman A.; The growing role of nanotechnology in combating infectious disease. Virulence 2011,2(5),395-401","journal-title":"Virulence"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/21691401.2014.953633","volume":"44","author":"Daraee H.","year":"2016","unstructured":"Daraee H.; Etemadi A.; Kouhi M.; Alimirzalu S.; Akbarzadeh A.; Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol 2016,44(1),381-391","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0031-6865(95)00010-7","volume":"70","author":"Vemuri S.","year":"1995","unstructured":"Vemuri S.; Rhodes C.T.; Preparation and characterization of liposomes as therapeutic delivery systems: A review. Pharmaceutica Acta Helvetiae 1995,70(2),95-111","journal-title":"Pharmaceutica Acta Helvetiae"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.trac.2005.07.006","volume":"25","author":"Gomezhens A.","year":"2006","unstructured":"Gomezhens A.; Fernandezromero J.; Analytical methods for the control of liposomal delivery systems. Trends Analyt Chem 2006,25(2),167-178","journal-title":"Trends Analyt Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00914037.2017.1332623","volume":"67","author":"Amoabediny G.","year":"2018","unstructured":"Amoabediny G.; Haghiralsadat F.; Naderinezhad S.; Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. Int J Polym Mater 2018,67(6),383-400","journal-title":"Int J Polym Mater"},{"key":"ref=52","first-page":"475","author":"Baselga J.","year":"2000","unstructured":"Baselga J.; Metselaar J.M.;  Monoclonal antibodies: clinical applications: monoclonal antibodies directed against growth factor receptors 2000,475-489","journal-title":"Monoclonal antibodies: clinical applications: monoclonal antibodies directed against growth factor receptors"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","volume":"154","author":"Sharma A.","year":"1997","unstructured":"Sharma A.; Sharma U.S.; Liposomes in drug delivery: Progress and limitations. Int J Pharm 1997,154(2),123-140","journal-title":"Int J Pharm"},{"key":"ref=54","first-page":"62","volume":"5","author":"Kalepu S.","year":"2013","unstructured":"Kalepu S.; Sunilkumar K.T.; Betha S.; Mohanvarma M.; Liposomal drug delivery system-a comprehensive review. Int J Drug Dev Res 2013,5(4),62-75","journal-title":"Int J Drug Dev Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/cmdc.201300563","volume":"9","author":"Mastrangelo E.","year":"2014","unstructured":"Mastrangelo E.; Mazzitelli S.; Fabbri J.; Delivery of suramin as an antiviral agent through liposomal systems. ChemMedChem 2014,9(5),933-939","journal-title":"ChemMedChem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1128\/jvi.63.7.2951-2958.1989","volume":"63","author":"Ho R.J.","year":"1989","unstructured":"Ho R.J.; Burke R.L.; Merigan T.C.; Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs. J Virol 1989,63(7),2951-2958","journal-title":"J Virol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.addr.2003.10.037","volume":"56","author":"Fattal E.","year":"2004","unstructured":"Fattal E.; Couvreur P.; Dubernet C.; \u201cSmart\u201d delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Adv Drug Deliv Rev 2004,56(7),931-946","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"Paliwal R.","year":"2020","unstructured":"Paliwal R.; Paliwal S.R.; Kenwat R.; Kurmi B.D.; Sahu M.K.; Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat 2020,30(3),179-194","journal-title":"Expert Opin Ther Pat"},{"key":"ref=59","first-page":"80","volume":"2","author":"Sathali A.H.","year":"2012","unstructured":"Sathali A.H.; Ekambaram P.; Priyanka K.; Solid lipid nanoparticles: A review. Sci Rev Chem Commun 2012,2(1),80-102","journal-title":"Sci Rev Chem Commun"},{"key":"ref=60","first-page":"8","volume":"5","author":"Yadav N.","year":"2013","unstructured":"Yadav N.; Khatak S.; Sara U.S.; Solid lipid nanoparticles-a review. Int J Appl Pharm 2013,5(2),8-18","journal-title":"Int J Appl Pharm"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-642-19792-5_5","author":"Guimar\u00e3es K.L.","year":"2011","unstructured":"Guimar\u00e3es K.L.; R\u00e9 M.I.; Lipid nanoparticles as carriers for cosmetic ingredients: The first (SLN) and the second generation (NLC). In: Nanocosmetics and nanomedicines 2011,101-22","journal-title":"Nanocosmetics and nanomedicines"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"Pardeike J.","year":"2009","unstructured":"Pardeike J.; Hommoss A.; M\u00fcller R.H.; Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009,366(1-2),170-184","journal-title":"Int J Pharm"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"M\u00fcller R.H.","year":"2000","unstructured":"M\u00fcller R.H.; M\u00e4der K.; Gohla S.; Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000,50(1),161-177","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/17425247.2012.673278","volume":"9","author":"Battaglia L.","year":"2012","unstructured":"Battaglia L.; Gallarate M.; Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012,9(5),497-508","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jcis.2009.03.012","volume":"334","author":"Helgason T.","year":"2009","unstructured":"Helgason T.; Awad T.S.; Kristbergsson K.; McClements D.J.; Weiss J.; Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci 2009,334(1),75-81","journal-title":"J Colloid Interface Sci"},{"key":"ref=66","first-page":"61","volume":"56","author":"Gohla S.H.","year":"2001","unstructured":"Gohla S.H.; Dingler A.; Scaling up feasibility of the production of solid lipid nanoparticles (SLN). Pharmazie 2001,56(1),61-63","journal-title":"Pharmazie"},{"key":"ref=67","first-page":"213","author":"Souto E.B.","year":"2007","unstructured":"Souto E.B.; M\u00fcller R.H.; Lipid nanoparticles (solid lipid nanoparticles and nanostructured lipid carriers) for cosmetic, dermal, and transdermal applications. In. Nanoparticulate drug delivery systems 2007,213-233","journal-title":"Nanoparticulate drug delivery systems"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jconrel.2003.08.006","volume":"93","author":"Lockman P.R.","year":"2003","unstructured":"Lockman P.R.; Oyewumi M.O.; Koziara J.M.; Roder K.E.; Mumper R.J.; Allen D.D.; Brain uptake of thiamine-coated nanoparticles. JCR 2003,93(3),271-282","journal-title":"JCR"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"Mehnert W.","year":"2012","unstructured":"Mehnert W.; M\u00e4der K.; Solid lipid nanoparticles. Adv Drug Deliv Rev 2012,64(64),83-101","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"Naseri N.","year":"2015","unstructured":"Naseri N.; Valizadeh H.; Zakeri-Milani P.; Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull 2015,5(3),305-313","journal-title":"Adv Pharm Bull"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3329\/icpj.v1i11.12065","volume":"1","author":"Garud A.","year":"2012","unstructured":"Garud A.; Singh D.; Garud N.; Solid lipid nanoparticles (SLN): Method, characterization and applications. Int Curr Pharm J 2012,1(11),384-393","journal-title":"Int Curr Pharm J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"26777","DOI":"10.1039\/D0RA03491F","volume":"10","author":"Duan Y.","year":"2020","unstructured":"Duan Y.; Dhar A.; Patel C.; A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC Advances 2020,10(45),26777-26791","journal-title":"RSC Advances"},{"key":"ref=73","first-page":"67","author":"Lingayat V.J.","year":"2017","unstructured":"Lingayat V.J.; Zarekar N.S.; Shendge R.S.; Solid lipid nanoparticles: A review. J Nanosci Nanotechnol 2017(1),67-72","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40005-013-0087-y","volume":"43","author":"Yoon G.","year":"2013","unstructured":"Yoon G.; Park J.W.; Yoon I.S.; Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): Recent advances in drug delivery. J Pharm Investig 2013,43(5),353-362","journal-title":"J Pharm Investig"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2174\/1389201017666160415155457","volume":"17","author":"Rajabi M.A.","year":"2016","unstructured":"Rajabi M.A.; Mousa S.; Lipid nanoparticle and their application in nanomedicine. Curr Pharm Biotechnol 2016,17(8),662-672","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.addr.2007.04.012","volume":"59","author":"M\u00fcller R.H.","year":"2007","unstructured":"M\u00fcller R.H.; Petersen R.D.; Hommoss A.; Pardeike J.; Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007,59(6),522-530","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejps.2017.11.023","volume":"112","author":"Garc\u00eas A.","year":"2018","unstructured":"Garc\u00eas A.; Amaral M.H.; Sousa Lobo J.M.; Silva A.C.; Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Eur J Pharm Sci 2018,112,159-167","journal-title":"Eur J Pharm Sci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"Mukherjee S.","year":"2009","unstructured":"Mukherjee S.; Ray S.; Thakur R.S.; Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J Pharm Sci 2009,71(4),349-358","journal-title":"Indian J Pharm Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-662-47862-2_11","author":"M\u00fcller R.H.","year":"2016","unstructured":"M\u00fcller R.H.; Alexiev U.; Sinambela P.; Keck C.M.; Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles. In: Percutaneous penetration enhancers chemical methods in penetration enhancement 2016,161-185","journal-title":"Percutaneous penetration enhancers chemical methods in penetration enhancement"},{"key":"ref=80","first-page":"392","volume":"53","author":"Cavalli R.","year":"1998","unstructured":"Cavalli R.; Caputo O.; Marengo E.; Pattarino F.; Gasco M.R.; The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Pharmazie 1998,53(6),392-396","journal-title":"Pharmazie"},{"key":"ref=81","first-page":"960","volume":"65","author":"Lason E.","year":"2011","unstructured":"Lason E.; Ogonowski J.; Solid Lipid Nanoparticles\u2013characteristics, application and obtaining. Chemik 2011,65(10),960-967","journal-title":"Chemik"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","volume":"10","author":"Mishra V.","year":"2018","unstructured":"Mishra V.; Bansal K.; Verma A.; Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics 2018,10(4),191","journal-title":"Pharmaceutics"},{"key":"ref=83","first-page":"52","volume":"9","author":"Gasco M.R.","year":"1997","unstructured":"Gasco M.R.; Solid Lipid Nanospheres from Warm Micro-Emulsions: Improvements in SLN production for more efficient drug delivery. Pharm Technol Eur 1997,9,52-58","journal-title":"Pharm Technol Eur"},{"key":"ref=84","first-page":"346","volume":"20","author":"Boltri L.","year":"1993","unstructured":"Boltri L.; Canal T.; Esposito P.A.; Carli F.; Lipid nanoparticles: evaluation of some critical formulation parameters. Proc Int Symp Control Release Bioact Mater 1993,20,346-347","journal-title":"Proc Int Symp Control Release Bioact Mater"},{"key":"ref=85","first-page":"110","volume":"42","author":"Cavalli R.","year":"1996","unstructured":"Cavalli R.; Marengo E.; Rodriguez L.; Gasco M.R.; Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm 1996,42(2),110-115","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","volume":"56","author":"Wissing S.A.","year":"2004","unstructured":"Wissing S.A.; Kayser O.; M\u00fcller R.H.; Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004,56(9),1257-1272","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=87","first-page":"431","volume":"61","author":"Souto E.B.","year":"2006","unstructured":"Souto E.B.; M\u00fcller R.H.; The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie 2006,61(5),431-437","journal-title":"Pharmazie"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/S0142-9612(01)00362-3","volume":"23","author":"Cortesi R.","year":"2002","unstructured":"Cortesi R.; Esposito E.; Luca G.; Nastruzzi C.; Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002,23(11),2283-2294","journal-title":"Biomaterials"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/sj.gt.3302699","volume":"13","author":"Hayes M.E.","year":"2006","unstructured":"Hayes M.E.; Drummond D.C.; Kirpotin D.B.; Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery. Gene Ther 2006,13(7),646-651","journal-title":"Gene Ther"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.09.014","volume":"495","author":"Makwana V.","year":"2015","unstructured":"Makwana V.; Jain R.; Patel K.; Nivsarkar M.; Joshi A.; Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm 2015,495(1),439-446","journal-title":"Int J Pharm"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"103773","DOI":"10.1016\/j.jff.2019.103773","volume":"65","author":"Su L.","year":"2020","unstructured":"Su L.; Zhou F.; Yu M.; Solid lipid nanoparticles enhance the resistance of oat-derived peptides that inhibit dipeptidyl peptidase IV in simulated gastrointestinal fluids. J Funct Foods 2020,65,103773","journal-title":"J Funct Foods"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/QAI.0000000000001170","volume":"74","author":"Guo D.","unstructured":"Guo D.; Zhou T.; Ara\u00ednga M.; Creation of a long-acting nanoformulated 2\u2032, 3\u2032-dideoxy-3\u2032-thiacytidine. J Acquir Immune Defic Syndr ,74(3),e75","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2010.11.037","volume":"83","author":"Kuo Y.C.","year":"2011","unstructured":"Kuo Y.C.; Chung J.F.; Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf B Biointerfaces 2011,83(2),299-306","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/cplu.202000460","volume":"85","author":"Liang L.","year":"2020","unstructured":"Liang L.; Ahamed A.; Ge L.; Fu X.; Lisak G.; Advances in antiviral material development. ChemPlusChem 2020,85(9),2105-2128","journal-title":"ChemPlusChem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1021\/acsomega.9b00304","volume":"4","author":"Kanwar R.","unstructured":"Kanwar R.; Rathee J.; Salunke D.B.; Mehta S.K.; Green nanotechnology-driven drug delivery assemblies. ACS Omega ,4(5),8804-8815","journal-title":"ACS Omega"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/nano10122464","volume":"10","author":"Demisli S.","year":"2020","unstructured":"Demisli S.; Mitsou E.; Pletsa V.; Xenakis A.; Papadimitriou V.; Development and study of nanoemulsions and nanoemulsion-based hydrogels for the encapsulation of lipophilic compounds. Nanomaterials (Basel) 2020,10(12),2464","journal-title":"Nanomaterials (Basel)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","volume":"252","author":"Singh Y.","year":"2017","unstructured":"Singh Y.; Meher J.G.; Raval K.; Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release 2017,252,28-49","journal-title":"J Control Release"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"R635","DOI":"10.1088\/0953-8984\/18\/41\/R01","volume":"18","author":"Mason T.G.","year":"2006","unstructured":"Mason T.G.; Wilking J.N.; Meleson K.; Chang C.B.; Graves S.M.; Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter 2006,18(41),R635-R666","journal-title":"J Phys Condens Matter"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1039\/C5SM02958A","volume":"12","author":"Gupta A.","year":"2016","unstructured":"Gupta A.; Eral H.B.; Hatton T.A.; Doyle P.S.; Nanoemulsions: formation, properties and applications. Soft Matter 2016,12(11),2826-2841","journal-title":"Soft Matter"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.foodhyd.2014.12.031","volume":"46","author":"Komaiko J.","year":"2015","unstructured":"Komaiko J.; McClements D.J.; Food-grade nanoemulsion filled hydrogels formed by spontaneous emulsification and gelation: Optical properties, rheology, and stability. Food Hydrocoll 2015,46,67-75","journal-title":"Food Hydrocoll"},{"key":"ref=101","author":"Jones T.A.","year":"2010","unstructured":"Jones T.A.; Clark D.E.; Quintero L.; inventors Baker Hughes Inc, assignee Microemulsions to convert OBM filter cakes to WBM filter cakes having filtration control United States patent US 7,709,421 2010","journal-title":"Baker Hughes Inc, assignee Microemulsions to convert OBM filter cakes to WBM filter cakes having filtration control United States patent US 7,709,421"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-5173(91)90361-Q","volume":"69","author":"Gasco M.R.","year":"1991","unstructured":"Gasco M.R.; Gallarate M.; Pattarino F.; In vitro permeation of azelaic acid from viscosized microemulsions. Int J Pharm 1991,69(3),193-196","journal-title":"Int J Pharm"},{"key":"ref=103","first-page":"201","author":"Sharma S.N.","year":"1985","unstructured":"Sharma S.N.; Jain N.K.;  A text book of professional pharmacy 1985,201","journal-title":"A text book of professional pharmacy"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijpharm.2004.05.016","volume":"280","author":"Bouchemal K.","year":"2004","unstructured":"Bouchemal K.; Brian\u00e7on S.; Perrier E.; Fessi H.; Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int J Pharm 2004,280(1-2),241-251","journal-title":"Int J Pharm"},{"key":"ref=105","first-page":"4640","volume":"3","author":"Patel R.P.","year":"2012","unstructured":"Patel R.P.; Joshi J.R.; An overview on nanoemulsion: A novel approach. Int J Pharm 2012,3(12),4640","journal-title":"Int J Pharm"},{"key":"ref=106","first-page":"4","volume":"32","author":"Shakeel F.","year":"2008","unstructured":"Shakeel F.; Baboota S.; Ahuja A.; Ali J.; Faisal M.S.; Shafiq S.; Stability evaluation of celecoxib nanoemulsion containing Tween 80. Thaiphesatchasan 2008,32,4-9","journal-title":"Thaiphesatchasan"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1016\/j.vaccine.2019.08.077","volume":"37","author":"Bernstein D.I.","year":"2019","unstructured":"Bernstein D.I.; Cardin R.D.; Bravo F.J.; Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes. Vaccine 2019,37(43),6470-6477","journal-title":"Vaccine"},{"key":"ref=108","first-page":"103","volume":"10","author":"Jadhav R.P.","year":"2020","unstructured":"Jadhav R.P.; Koli V.W.; Kamble A.B.; Bhutkar M.A.; A Review on Nanoemulsion. Asian J Pharm 2020,10(2),103-108","journal-title":"Asian J Pharm"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"40100","DOI":"10.1039\/D1RA06101A","volume":"11","author":"Tabatabaeinejad S.M.","year":"2021","unstructured":"Tabatabaeinejad S.M.; Zinatloo-Ajabshir S.; Amiri O.; Salavati-Niasari M.; Magnetic Lu 2 Cu 2 O 5 -based ceramic nanostructured materials fabricated by a simple and green approach for an effective photocatalytic degradation of organic contamination. RSC Advances 2021,11(63),40100-40111","journal-title":"RSC Advances"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"30178","DOI":"10.1016\/j.ceramint.2021.07.197","volume":"47","author":"Zinatloo-Ajabshir S.","year":"2021","unstructured":"Zinatloo-Ajabshir S.; Baladi M.; Salavati-Niasari M.; Sono-synthesis of MnWO4 ceramic nanomaterials as highly efficient photocatalysts for the decomposition of toxic pollutants. Ceram Int 2021,47(21),30178-30187","journal-title":"Ceram Int"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/pharmaceutics11050230","volume":"11","author":"Shah J.","year":"2019","unstructured":"Shah J.; Nair A.B.; Jacob S.; Nanoemulsion based vehicle for effective ocular delivery of moxifloxacin using experimental design and pharmacokinetic study in rabbits. Pharmaceutics 2019,11(5),230","journal-title":"Pharmaceutics"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.30750\/ijpbr.2.1.19","volume":"2","author":"Bhosale R.R.","year":"2014","unstructured":"Bhosale R.R.; Osmani R.A.; Ghodake P.P.; Shaikh S.M.; Chavan S.R.; Nanoemulsion: A review on novel profusion in advanced drug delivery. Indian J Pharm Biol Res 2014,2(01),122-127","journal-title":"Indian J Pharm Biol Res"},{"key":"ref=113","first-page":"63","author":"Leong K.H.","year":"2022","unstructured":"Leong K.H.; Ng J.J.; Sim L.C.; Saravanan P.; Dai C.; Tan B.;  Biogenic synthesis of nanoparticulate materials for antiviral applications 2022,63-76","journal-title":"Biogenic synthesis of nanoparticulate materials for antiviral applications"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/1061186X.2017.1419363","volume":"26","author":"Mu Q.","year":"2018","unstructured":"Mu Q.; Yu J.; McConnachie L.A.; Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook. J Drug Target 2018,26(5-6),435-447","journal-title":"J Drug Target"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","volume":"21","author":"Kwon G.S.","year":"1996","unstructured":"Kwon G.S.; Okano T.; Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 1996,21(2),107-116","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/apmc.1984.051230121","volume":"123","author":"Bader H.","year":"1984","unstructured":"Bader H.; Ringsdorf H.; Schmidt B.; Watersoluble polymers in medicine. Angew Makromol Chem 1984,123(1),457-485","journal-title":"Angew Makromol Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/1061186X.2014.934688","volume":"22","author":"Yokoyama M.","year":"2014","unstructured":"Yokoyama M.; Polymeric micelles as drug carriers: Their lights and shadows. J Drug Target 2014,22(7),576-583","journal-title":"J Drug Target"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.reactfunctpolym.2010.10.009","volume":"71","author":"Miyata K.","year":"2011","unstructured":"Miyata K.; Christie R.J.; Kataoka K.; Polymeric micelles for nano-scale drug delivery. React Funct Polym 2011,71(3),227-234","journal-title":"React Funct Polym"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2012.09.013","volume":"64","author":"Kataoka K.","year":"2012","unstructured":"Kataoka K.; Harada A.; Nagasaki Y.; Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 2012,64,37-48","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","volume":"248","author":"Mandal A.","year":"2017","unstructured":"Mandal A.; Bisht R.; Rupenthal I.D.; Mitra A.K.; Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies. J Control Release 2017,248,96-116","journal-title":"J Control Release"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/pj.2017.67","volume":"50","author":"Harada A.","year":"2018","unstructured":"Harada A.; Kataoka K.; Polyion complex micelle formation from double-hydrophilic block copolymers composed of charged and non-charged segments in aqueous media. Polym J 2018,50(1),95-100","journal-title":"Polym J"},{"key":"ref=122","first-page":"128","volume":"45","author":"Mourya V.K.","year":"2011","unstructured":"Mourya V.K.; Inamdar N.; Nawale R.B.; Kulthe S.S.; Polymeric micelles: general considerations and their applications. Indian J Pharm Educ Res 2011,45(2),128-138","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"Nazila K.","year":"2016","unstructured":"Nazila K.; Yameen B.; Wu J.; Farokhzad O.C.; Nanoparticles: Mechanisms of controlling drug release nazila. Chem Rev 2016,116,2602-2663","journal-title":"Chem Rev"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","volume":"48","author":"Jones M.C.","year":"1999","unstructured":"Jones M.C.; Leroux J.C.; Polymeric micelles-A new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999,48(2),101-111","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3851\/IMP1684","volume":"21","author":"Lembo D.","year":"2010","unstructured":"Lembo D.; Cavalli R.; Nanoparticulate delivery systems for antiviral drugs. Antivir Chem Chemother 2010,21(2),53-70","journal-title":"Antivir Chem Chemother"},{"key":"ref=126","first-page":"71","volume":"2","author":"Kothamasu P.","year":"2012","unstructured":"Kothamasu P.; Kanumur H.; Ravur N.; Maddu C.; Parasuramrajam R.; Thangavel S.; Nanocapsules: the weapons for novel drug delivery systems. Bioimpacts 2012,2(2),71-81","journal-title":"Bioimpacts"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, et al. Polymeric nanoparticles: Production, characterization, toxicology and ecotoxicology. Molecules 2020,25(16),3731","journal-title":"Molecules"},{"key":"ref=128","first-page":"155","volume":"Vol. 2","author":"Birnbaum D.T.","year":"2004","unstructured":"Birnbaum D.T.; Brannon-Peppas L.; Microparticle Drug Delivery Systems. Drug Delivery Systems in Cancer Therapy Cancer Drug Discovery and Development 2004,Vol. 2,155-181","journal-title":"Drug Delivery Systems in Cancer Therapy Cancer Drug Discovery and Development"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1021\/ja909475m","volume":"132","author":"Shen Y.","year":"2010","unstructured":"Shen Y.; Jin E.; Zhang B.; Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc 2010,132(12),4259-4265","journal-title":"J Am Chem Soc"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2008.02.007","volume":"128","author":"Anton N.","year":"2008","unstructured":"Anton N.; Benoit J.P.; Saulnier P.; Design and production of nanoparticles formulated from nano-emulsion templates-A review. J Control Release 2008,128(3),185-199","journal-title":"J Control Release"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/adma.19930050603","volume":"5","author":"Novak B.M.","year":"1993","unstructured":"Novak B.M.; Hybrid nanocomposite materials between inorganic glasses and organic polymers. Adv Mater 1993,5(6),422-433","journal-title":"Adv Mater"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijpharm.2008.02.005","volume":"358","author":"Fonseca L.S.","year":"2008","unstructured":"Fonseca L.S.; Silveira R.P.; Deboni A.M.; Nanocapsule@xerogel microparticles containing sodium diclofenac: A new strategy to control the release of drugs. Int J Pharm 2008,358(1-2),292-295","journal-title":"Int J Pharm"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"9908","DOI":"10.1021\/ja1039242","volume":"132","author":"Kim D.","year":"2010","unstructured":"Kim D.; Kim E.; Lee J.; Direct synthesis of polymer nanocapsules: self-assembly of polymer hollow spheres through irreversible covalent bond formation. J Am Chem Soc 2010,132(28),9908-9919","journal-title":"J Am Chem Soc"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1023\/A:1016121319668","volume":"19","author":"Heurtault B.","year":"2002","unstructured":"Heurtault B.; Saulnier P.; Pech B.; Proust J.E.; Benoit J.P.; A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002,19(6),875-880","journal-title":"Pharm Res"},{"key":"ref=135","first-page":"1028","volume":"22","author":"Chola M.","year":"2019","unstructured":"Chola M.; Kumar R.; Kumar R.; Vyas M.; Recent pharmaceutical interventions in the treatment of HIV\/AIDS. Think India Jour 2019,22(30),1028-1039","journal-title":"Think India Jour"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2217\/nnm.10.71","volume":"5","author":"Sanchis J.","year":"2010","unstructured":"Sanchis J.; Canal F.; Lucas R.; Vicent M.J.; Polymer\u2013drug conjugates for novel molecular targets. Nanomedicine (Lond) 2010,5(6),915-935","journal-title":"Nanomedicine (Lond)"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"Ekladious I.","year":"2019","unstructured":"Ekladious I.; Colson Y.L.; Grinstaff M.W.; Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov 2019,18(4),273-294","journal-title":"Nat Rev Drug Discov"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2014.09.009","volume":"194","author":"Lv S.","year":"2014","unstructured":"Lv S.; Tang Z.; Zhang D.; Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel. J Control Release 2014,194,220-227","journal-title":"J Control Release"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.addr.2009.01.007","volume":"61","author":"Yurkovetskiy A.V.","year":"2009","unstructured":"Yurkovetskiy A.V.; Fram R.J.; XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer. Adv Drug Deliv Rev 2009,61(13),1193-1202","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1517\/17425247.5.1.87","volume":"5","author":"Brumlik M.J.","year":"2008","unstructured":"Brumlik M.J.; Daniel B.J.; Waehler R.; Curiel D.T.; Giles F.J.; Curiel T.J.; Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Expert Opin Drug Deliv 2008,5(1),87-103","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jconrel.2015.09.043","volume":"219","author":"Li J.","year":"2015","unstructured":"Li J.; Yu F.; Chen Y.; Oupick\u00fd D.; Polymeric drugs: Advances in the development of pharmacologically active polymers. J Control Release 2015,219,369-382","journal-title":"J Control Release"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.bi.60.070191.002303","volume":"60","author":"Kjell\u00e9n L.","year":"1991","unstructured":"Kjell\u00e9n L.; Lindahl U.; Proteoglycans: structures and interactions. Annu Rev Biochem 1991,60(1),443-475","journal-title":"Annu Rev Biochem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.1039\/C4PY00624K","volume":"5","author":"Smith A.A.A.","year":"2014","unstructured":"Smith A.A.A.; Kryger M.B.L.; Wohl B.M.; Macromolecular (pro)drugs in antiviral research. Polym Chem 2014,5(22),6407-6425","journal-title":"Polym Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2012.06.008","volume":"168","author":"Mateu M.G.","year":"2012","unstructured":"Mateu M.G.; Mechanical properties of viruses analyzed by atomic force microscopy: A virological perspective. Virus Res 2012,168(1-2),1-22","journal-title":"Virus Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.142","volume":"1","author":"Thi EP","year":"2016","unstructured":"Thi EP; Lee AC; Geisbert JB; Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nature microb 2016,1(10),1-0","journal-title":"Nature microb"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.3390\/md13085156","volume":"13","author":"Cheung R.","year":"2015","unstructured":"Cheung R.; Ng T.; Wong J.; Chan W.; Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs 2015,13(8),5156-5186","journal-title":"Mar Drugs"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-8-1","volume":"8","author":"Lara H.H.","year":"2010","unstructured":"Lara H.H.; Ayala-Nu\u00f1ez N.V.; Ixtepan-Turrent L.; Rodriguez-Padilla C.; Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotech 2010,8(1),1","journal-title":"J Nanobiotech"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1166\/jbn.2008.012","volume":"4","author":"Sun L.","year":"2008","unstructured":"Sun L.; Singh A.K.; Vig K.; Pillai S.R.; Singh S.R.; Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Nanotechnol 2008,4(2),149-158","journal-title":"J Biomed Nanotechnol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.msec.2016.12.073","volume":"73","author":"Nayak D.","year":"2017","unstructured":"Nayak D.; Boxi A.; Ashe S.; Thathapudi N.C.; Nayak B.; Stavudine loaded gelatin liposomes for HIV therapy: Preparation, characterization and in vitro cytotoxic evaluation. Mater Sci Eng C 2017,73,406-416","journal-title":"Mater Sci Eng C"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","volume":"347","author":"Vyas T.K.","year":"2008","unstructured":"Vyas T.K.; Shahiwala A.; Amiji M.M.; Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm 2008,347(1-2),93-101","journal-title":"Int J Pharm"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.apsb.2013.08.001","volume":"3","author":"Prabhakar K.","year":"2013","unstructured":"Prabhakar K.; Afzal S.M.; Surender G.; Kishan V.; Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharm Sin B 2013,3(5),345-353","journal-title":"Acta Pharm Sin B"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ejpb.2007.07.005","volume":"68","author":"Feng M.","year":"2008","unstructured":"Feng M.; Cai Q.; Huang H.; Zhou P.; Liver targeting and anti-HBV activity of reconstituted HDL\u2013acyclovir palmitate complex. Eur J Pharm Biopharm 2008,68(3),688-693","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"Khosa A.","year":"2018","unstructured":"Khosa A.; Reddi S.; Saha R.N.; Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother 2018,103,598-613","journal-title":"Biomed Pharmacother"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/nnm.09.90","volume":"5","author":"Chiappetta D.A.","year":"2010","unstructured":"Chiappetta D.A.; Hocht C.; Taira C.; Sosnik A.; Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability. Nanomedicine (Lond) 2010,5(1),11-23","journal-title":"Nanomedicine (Lond)"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.colsurfb.2014.08.011","volume":"122","author":"Sawdon A.J.","year":"2014","unstructured":"Sawdon A.J.; Peng C.A.; Polymeric micelles for acyclovir drug delivery. Colloids Surf B Biointerfaces 2014,122,738-745","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ejps.2010.08.004","volume":"41","author":"Li Q.","year":"2010","unstructured":"Li Q.; Du Y.Z.; Yuan H.; Synthesis of Lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system. Eur J Pharm Sci 2010,41(3-4),498-507","journal-title":"Eur J Pharm Sci"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4591634","volume":"2016","author":"Hassan H.","year":"2016","unstructured":"Hassan H.; Adam S.K.; Othman F.; Shamsuddin A.F.; Basir R.; Antiviral nanodelivery systems: current trends in acyclovir administration. J Nanomater 2016,2016,1-8","journal-title":"J Nanomater"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1039\/C7NR06520E","volume":"9","author":"Yang X.X.","year":"2017","unstructured":"Yang X.X.; Li C.M.; Li Y.F.; Wang J.; Huang C.Z.; Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection. Nanoscale 2017,9(41),16086-16092","journal-title":"Nanoscale"},{"key":"ref=159","first-page":"548","volume":"82","year":"2014","unstructured":"lannazzo D, Pistone A, Galvagno S, Ferro S, De Luca L, Maria A. Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes. Carbon 2014,82,548-561","journal-title":"Carbon"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"338548","DOI":"10.1016\/j.aca.2021.338548","volume":"1166","author":"Gogola J.L.","year":"2021","unstructured":"Gogola J.L.; Martins G.; Gevaerd A.; Label-free aptasensor for p24-HIV protein detection based on graphene quantum dots as an electrochemical signal amplifier. Anal Chim Acta 2021,1166,338548","journal-title":"Anal Chim Acta"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"35290","DOI":"10.1039\/C7RA06477B","volume":"7","author":"Lin Z.","year":"2017","unstructured":"Lin Z.; Li Y.; Guo M.; Inhibition of H1N1 influenza virus by selenium nanoparticles loaded with zanamivir through p38 and JNK signaling pathways. RSC Advances 2017,7(56),35290-35296","journal-title":"RSC Advances"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/2211738507666191210163408","volume":"8","author":"Nabila N","year":"2020","unstructured":"Nabila N; Suada NK; Denis D; Antiviral action of curcumin encapsulated in nanoemulsion against four serotypes of dengue virus. Pharma nanotech 2020,8(1),54-62","journal-title":"Pharma nanotech"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13404-017-0213-0","volume":"50","author":"Borker S.","year":"2017","unstructured":"Borker S.; Patole M.; Moghe A.; Pokharkar V.; Engineering of pectin-reduced gold nanoparticles for targeted delivery of an antiviral drug to macrophages: in vitro and in vivo assessment. Gold Bull 2017,50(3),235-246","journal-title":"Gold Bull"},{"key":"ref=164","author":"Joshy K.S.","year":"2017","unstructured":"Joshy K.S.; Snigdha S.; Kalarikkal N.; Pothen L.A.; Thomas S.; Gelatin modified lipid nanoparticles for anti retroviral drug delivery. Chem Phys Lipids 2017","journal-title":"Chem Phys Lipids"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ijbiomac.2017.05.094","volume":"103","author":"Joshy K.S.","year":"2017","unstructured":"Joshy K.S.; George A.; Jose J.; Kalarikkal N.; Pothen L.A.; Thomas S.; Novel dendritic structure of alginate hybrid nanoparticles for effective anti-viral drug delivery. Int J Biol Macromol 2017,103,1265-1275","journal-title":"Int J Biol Macromol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.msec.2018.08.015","volume":"93","author":"Joshy K.S.","year":"2018","unstructured":"Joshy K.S.; George A.; Snigdha S.; Novel core-shell dextran hybrid nanosystem for anti-viral drug delivery. Mater Sci Eng C 2018,93,864-872","journal-title":"Mater Sci Eng C"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1039\/D0SC02658A","volume":"11","author":"Innocenzi P.","year":"2020","unstructured":"Innocenzi P.; Stagi L.; Carbon-based antiviral nanomaterials: graphene, C-dots, and fullerenes. A perspective. Chem Sci (Camb) 2020,11(26),6606-6622","journal-title":"Chem Sci (Camb)"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","volume":"85","author":"Hadinoto K.","year":"2013","unstructured":"Hadinoto K.; Sundaresan A.; Cheow W.S.; Lipid\u2013polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur J Pharm Biopharm 2013,85(3),427-443","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mimet.2019.03.017","volume":"160","author":"Dave V.","year":"2019","unstructured":"Dave V.; Tak K.; Sohgaura A.; Gupta A.; Sadhu V.; Reddy K.R.; Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications. J Microbiol Methods 2019,160,130-142","journal-title":"J Microbiol Methods"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jconrel.2017.12.016","volume":"271","author":"Date T.","year":"2018","unstructured":"Date T.; Nimbalkar V.; Kamat J.; Mittal A.; Mahato R.I.; Chitkara D.; Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics. J Control Release 2018,271,60-73","journal-title":"J Control Release"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1872211314666201204160641","volume":"14","author":"Malviya R.","year":"2021","unstructured":"Malviya R.; Tyagi V.; Singh D.; Techniques of mucilage and gum modification and their effect on hydrophilicity and drug release. Recent Pat Drug Deliv Formul 2021,14(3),214-222","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=172","first-page":"32","author":"Zhou G.","year":"2013","unstructured":"Zhou G.; Li R.; Vasen T.; Qi M.; Novel gate-recessed vertical InAs\/GaSb TFETs with record high ION of 180  \u03bcA\/\u03bcm at V DS= 0.5 V. In. International Electron Devices Meeting 2013,32-6","journal-title":"International Electron Devices Meeting"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"B77","DOI":"10.1016\/j.jacc.2017.09.249","volume":"70","author":"Schampaert E.","year":"2017","unstructured":"Schampaert E.; Serruys P.; Kappetein A.P.; TCT-181 outcomes of left main PCI vs. CABG according the number of diseased coronary arteries: The EXCEL trial. J Am Coll Cardiol 2017,70(18),B77","journal-title":"J Am Coll Cardiol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.2147\/IJN.S140939","volume":"12","author":"Li Y.","year":"2017","unstructured":"Li Y.; Lin Z.; Guo M.; Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus. Int J Nanomedicine 2017,12,5733-5743","journal-title":"Int J Nanomedicine"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1557\/adv.2018.320","volume":"3","author":"Manyarara T.E.","year":"2018","unstructured":"Manyarara T.E.; Khoza S.; Dube A.; Maponga C.C.; Formulation and characterization of a paediatric nanoemulsion dosage form with modified oral drug delivery system for improved dissolution rate of nevirapine. MRS Adv 2018,3(37),2203-2219","journal-title":"MRS Adv"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/nnm.16.1","volume":"11","author":"Shao J.","year":"2016","unstructured":"Shao J.; Kraft J.C.; Li B.; Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV\/AIDS. Nanomedicine (Lond) 2016,11(5),545-564","journal-title":"Nanomedicine (Lond)"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"e7423","DOI":"10.7759\/cureus.7423","volume":"12","author":"Pal M.","year":"2020","unstructured":"Pal M.; Berhanu G.; Desalegn C.; Kandi V.; Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update. Cureus 2020,12(3),e7423","journal-title":"Cureus"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41392-021-00527-1","volume":"6","author":"Wang C.","year":"2021","unstructured":"Wang C.; Wang Z.; Wang G.; Lau J.Y.N.; Zhang K.; Li W.; COVID-19 in early 2021: current status and looking forward. Signal Transduct Target Ther 2021,6(1),114","journal-title":"Signal Transduct Target Ther"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"Thanh Le T.","year":"2020","unstructured":"Thanh Le T.; Andreadakis Z.; Kumar A.; The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020,19(5),305-306","journal-title":"Nat Rev Drug Discov"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3390\/pharmaceutics13111895","volume":"13","author":"Jannat K.","year":"2021","unstructured":"Jannat K.; Paul A.K.; Bondhon T.A.; Nanotechnology applications of flavonoids for viral diseases. Pharmaceutics 2021,13(11),1895","journal-title":"Pharmaceutics"},{"key":"ref=181","first-page":"1598","volume":"1851","author":"Jamalipour Soufi G","year":"2020","unstructured":"Jamalipour Soufi G; Iravani S.;  Nanomaterials against pathogenic viruses: greener and sustainable approaches Inorg Nano-Met Chem 2020,1851(11),1598-614","journal-title":"Nanomaterials against pathogenic viruses: greener and sustainable approaches Inorg Nano-Met Chem"},{"key":"ref=182","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/IJN.S198353","volume":"14","author":"Mukherjee A.","year":"2019","unstructured":"Mukherjee A.; Waters A.K.; Kalyan P.; Achrol A.S.; Kesari S.; Yenugonda V.M.; Lipid\u2013polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine 2019,14,1937","journal-title":"Int J Nanomedicine"},{"key":"ref=183","first-page":"116893","volume":"10","author":"Badwaik HR","year":"2020","unstructured":"Badwaik HR; Al Hoque A; Kumari L; Sakure K; Baghel M; Giri TK;  Moringa gum and its modified form as a potential green polymer used in biomedical field Carbo Poly 2020,10,116893","journal-title":"Moringa gum and its modified form as a potential green polymer used in biomedical field Carbo Poly"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/2049936117713593","volume":"4","author":"Singh L.","year":"2017","unstructured":"Singh L.; Kruger H.G.; Maguire G.E.M.; Govender T.; Parboosing R.; The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis 2017,4(4),105-131","journal-title":"Ther Adv Infect Dis"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.2147\/IJN.S327334","volume":"16","author":"Yayehrad A.T.","year":"2021","unstructured":"Yayehrad A.T.; Siraj E.A.; Wondie G.B.; Alemie A.A.; Derseh M.T.; Ambaye A.S.; Could nanotechnology help to end the fight against COVID-19? Review of current findings, challenges and future perspectives. Int J Nanomedicine 2021,16,5713-5743","journal-title":"Int J Nanomedicine"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s42247-021-00165-x","volume":"4","author":"Ertas YN","year":"2021","unstructured":"Ertas YN; Mahmoodi M; Shahabipour F; Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). Emergent mater 2021,4(1),35-55","journal-title":"Emergent mater"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"Wang L.","year":"2017","unstructured":"Wang L.; Hu C.; Shao L.; The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine 2017,12,1227-1249","journal-title":"Int J Nanomedicine"},{"key":"ref=188","first-page":"112","volume":"36","author":"Sagadevan S.","year":"2014","unstructured":"Sagadevan S.; Periasamy M.; A review on role of nanostructures in drug delivery system. Rev Adv Mater Sci 2014,36,112-117","journal-title":"Rev Adv Mater Sci"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211738511666221201154154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211498\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211738511666221201154154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T17:56:46Z","timestamp":1692554206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211498\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":188,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211738511666221201154154","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}